ストックスクリーナーアプリを入手
9.09
2.74%
-0.21
Amylyx Pharmaceuticals Inc (AMLX) 最新ニュース
H.C. Wainwright, Leerink Partners, and TD Cowen Reaffirm ‘Buy’ Ratings on Amylyx Pharmaceuticals, Inc. (AMLX) - MSN
Signal strength of Amylyx Pharmaceuticals Inc. stock in tech scannersEntry Point & Free AI Powered Buy and Sell Recommendations - Newser
Amylyx Pharmaceuticals (AMLX): A High-Conviction Biotech Play with Avexitide's Groundbreaking Potential - AInvest
Analysts Reaffirm 'Buy' Ratings on Amylyx Pharmaceuticals with High Price Targets - AInvest
Amylyx Pharmaceuticals, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before April 9, 2024 to Discuss Your RightsAMLX - ACCESS Newswire
Full technical analysis of Amylyx Pharmaceuticals Inc. stockMarket Growth Report & Entry Point Confirmation Alerts - Newser
What data driven models say about Amylyx Pharmaceuticals Inc.’s futureMarket Movers & Advanced Swing Trade Entry Plans - Newser
Can Amylyx Pharmaceuticals Inc. stock outperform in a bear marketGold Moves & Weekly High Potential Alerts - kangso.co.kr
Market reaction to Amylyx Pharmaceuticals Inc.’s recent newsWeekly Trade Recap & Breakout Confirmation Alerts - Newser
How Amylyx Pharmaceuticals Inc. stock performs during market volatilityChart Signals & Safe Entry Momentum Tips - Newser
Can trapped investors hope for a rebound in Amylyx Pharmaceuticals Inc.Market Trend Report & Growth Oriented Trading Recommendations - Newser
Understanding Amylyx Pharmaceuticals Inc.’s price movementPortfolio Gains Summary & Free Community Supported Trade Ideas - Newser
Identifying reversal signals in Amylyx Pharmaceuticals Inc.July 2025 PostEarnings & Verified Chart Pattern Signals - Newser
Analyzing Amylyx Pharmaceuticals Inc. with multi timeframe chartsAnalyst Upgrade & Weekly High Conviction Ideas - Newser
11 Best Single Digit Stocks to Buy According to Hedge Funds - Insider Monkey
Amylyx Pharmaceuticals’ Promising Earnings Call Highlights - MSN
Can Amylyx Pharmaceuticals Inc. recover in the next quarterQuarterly Performance Summary & Verified Chart Pattern Trade Signals - Newser
Is Amylyx Pharmaceuticals Inc. reversing from oversold territoryPrice Action & Real-Time Volume Trigger Notifications - Newser
Why Amylyx Pharmaceuticals Inc. stock attracts strong analyst attention2025 Historical Comparison & Reliable Volume Spike Trade Alerts - 선데이타임즈
What technical models suggest about Amylyx Pharmaceuticals Inc.’s comeback - Newser
Drawdown in Amylyx Pharmaceuticals Inc. May Be Nearing EndMarket Risk Summary & Weekly Stock Breakout Alerts - metal.it
Will Amylyx Pharmaceuticals Inc. rebound enough to break evenMarket Sentiment Report & Real-Time Market Sentiment Alerts - Newser
Amylyx Pharmaceuticals Inc. Inches Above Key Support — Safe to Hold2025 Technical Patterns & Real-Time Market Sentiment Alerts - sundaytimes.kr
Has Amylyx Pharmaceuticals Inc. found a price floorWeekly Investment Recap & High Accuracy Trade Signal Alerts - Newser
What recovery options are there for Amylyx Pharmaceuticals Inc.Market Activity Summary & Consistent Income Trade Recommendations - Newser
Amylyx Pharmaceuticals Inc. Earnings Report Breakdown: What Investors Should Know2025 Analyst Calls & Fast Moving Market Watchlists - Newser
XTX Topco Ltd Sells 13,834 Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) - Defense World
Will Amylyx Pharmaceuticals Inc. benefit from geopolitical trendsMarket Trend Summary & Low Risk Entry Point Tips - newsyoung.net
Can Amylyx Pharmaceuticals Inc. ride the EV waveExit Point & Risk Managed Investment Entry Signals - newsyoung.net
Will Amylyx Pharmaceuticals Inc. benefit from rising consumer demandTrend Confirmation Stock Picks - thegnnews.com
Will Breakout in Amylyx Pharmaceuticals Inc. Sustain Through Next WeekAI Driven Stock Trend Forecast Shows Momentum Shift - beatles.ru
Amylyx Pharmaceuticals Advances ALS Treatment with AMX0114 Clinical Trial - MSN
Amylyx anticipates Avexitide Phase III data in H1 2026 while expanding rare disease pipeline - MSN
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q2 2025 Earnings Call Transcript - Insider Monkey
Amylyx Reports Q2 EPS of 46c, Meets Consensus Estimate - AInvest
Promising Market Potential and Financial Outlook for Amylyx Pharmaceuticals Inc. Driven by Avexitide’s Advancements - TipRanks
Amylyx Pharmaceuticals Q2 2025 Earnings Preview - MSN
Amylyx Pharmaceuticals: Progress in Trials and Financials - TipRanks
Amylyx Pharmaceuticals: Strategic Progress in Neurodegenerative Therapies and the Path to Long-Term Value - AInvest
Amylyx in 2026: A High-Risk, High-Reward Biotech Catalyst Play - AInvest
Progressive Supranuclear Palsy Market on Upward Trajectory During the Forecast Period (2025-2034) with Emerging Immunotherapies | DelveInsight - Yahoo Finance
Amylyx Pharmaceuticals' Q2 2025: Key Contradictions in PBH Patient Estimates, Trial Analysis, and Market Opportunities - AInvest
Amylyx Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Amylyx Pharmaceuticals’ Phase 3 Study on Avexitide: A Potential Game-Changer for Post-Bariatric Hypoglycemia - TipRanks
Promising Future for Amylyx Pharmaceuticals: Buy Rating Backed by Avexitide’s Market Potential - TipRanks
Amylyx (AMLX) Q2 Net Loss Narrows 43% - Nasdaq
Transcript : Amylyx Pharmaceuticals, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Amylyx Pharmaceuticals Reports Second Quarter 2025 Financial Results - BioSpace
Amylyx Pharmaceuticals, Inc. SEC 10-Q Report - TradingView
Amylyx Pharma Q2 net loss wider than expected as R&D costs increase - TradingView
Amylyx Pharmaceuticals: A Biotech Undervalued by Momentum and Milestones - AInvest
Amylyx Pharmaceuticals Advances Avexitide Study for Post-Bariatric Hypoglycemia - TipRanks
Amylyx Pharmaceuticals’ ALS Study: A Potential Game-Changer for Investors - TipRanks
Amylyx Pharmaceuticals Inc expected to post a loss of 45 cents a shareEarnings Preview - TradingView
After strategic reset, Amylyx downsizes, moves Cambridge HQ - The Business Journals
How volatile is Amylyx Pharmaceuticals Inc. stock compared to the marketAchieve exceptional returns with expert guidance - Jammu Links News
What is the dividend policy of Amylyx Pharmaceuticals Inc. stockMaximize gains with proven stock analysis - Jammu Links News
What are analysts’ price targets for Amylyx Pharmaceuticals Inc. in the next 12 monthsSkyrocketing profit margins - Jammu Links News
What are the latest earnings results for Amylyx Pharmaceuticals Inc.Build wealth with long-term growth strategies - Jammu Links News
0.12%
0.57%
大文字化:
|
ボリューム (24 時間):